Memorial Sloan Kettering Cancer Center
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Memorial Sloan Kettering Cancer Center sits in the top decile of US sponsors by registered trial count (#6 of 15,751 sponsors by registered trial count).
Memorial Sloan Kettering Cancer Center: 1,884 sponsored US clinical trials, 327 recruiting.
Memorial Sloan Kettering Cancer Center sponsors 1,884 registered US clinical trials on ClinicalTrials.gov, 327 of them currently recruiting, and 1,104 completed. 75 of these trials are in Phase 3-4 (later-stage) and 1,101 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Breast Cancer, with 98 trials.
Top-decile sponsor footprint
Memorial Sloan Kettering Cancer Center ranks in the top decile of sponsors by registered trial count (#6 of 15,751 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Open and recent trials
1,884 total, page 3 of 38
An Acupuncture Study for Cancer Survivors With Joint Pain
NCT06814977
A Study of Valemetostat in Combination With Atezolizumab in People With Lung Cancer
NCT06807632
A Study of Sotorasib in People With Brain Tumors
NCT06807619
A Study of SER-155 to Treat Diarrhea in People on Immunotherapy
NCT06801067
A Study of Glofitamab-based Treatment in People With Diffuse Large B-cell Lymphoma
NCT06765317
A Study of Breast Cancer Risk Factors and Outcomes of People in Florida
NCT06780176
A Study of Ruxolitinib in Combination With Ulixertinib in People With Myelofibrosis
NCT06773195
A Study of Azacitidine and Venetoclax in People With Acute Myeloid Leukemia (AML)
NCT06773208
A Study of Enasidenib in People With T-Cell Lymphoma
NCT06756308
A Study of a Weight Loss Intervention in People With Endometrial Cancer
NCT06751589
A Study of Stereotactic Radiosurgery (SRS) and Standard Treatment in People With Lung Cancer That Has Spread to the Brain
NCT06741085
A Study of Circulating Tumor DNA (ctDNA) Testing for People With B-Cell Lymphoma
NCT06736613
Enhanced Pain Coping in Cancer (EPIC): A Study of Managing Treatment-Related Joint Pain in Breast Cancer Survivors
NCT06728579
A Study of Lung Cancer Screening in People With Unexplained Weight Loss
NCT06717334
A Study of Language Interpretation Solutions for People With Breast Cancer
NCT06721065
A Study of Surgical Techniques During Cystectomy
NCT06703476
A Study of Abemaciclib and Radiation Therapy in People With Metastatic Breast Cancer
NCT06678269
A Study of Mogamulizumab to Prevent Adult T-cell Leukemia/Lymphoma in People With HTLV-1
NCT06698003
A Study Evaluating the Use of an Indoor Air Quality Monitor to Promote a Smoke-free Home
NCT06693700
A Study of Melphalan With or Without Siltuximab in People With Multiple Myeloma Having an Autologous Stem Cell Transplant
NCT06679829
A Study of the Use of 3D Technology to Guide Head and Neck Surgery
NCT06676592
A Study of Response to Standard Treatment Before Surgery in People With Rectal Cancer
NCT06637462
A Study on Pain After Breast Reconstruction
NCT06627582
A Study of Mesothelin-Targeted CAR T-Cell Therapy in People With Esophagogastric Cancer
NCT06623396
A Study of Fianlimab, Cemiplimab, and Ipilimumab in People With Melanoma
NCT06594991
A Study of Vemurafenib and Obinutuzumab Compared to Cladribine and Rituximab in People With Hairy Cell Leukemia (HCL)
NCT06561360
A Study of Sotorasib in People With Non-Small Cell Lung Cancer
NCT06582771
A Study Comparing Personalized Radiation Therapy With Standard Radiation Therapy in People With HPV-Positive Throat Cancer
NCT06563479
A Study Comparing Cancer Imaging Approaches in People With Lobular Breast Cancer
NCT06557148
Registry for Esophageal and Gastroesophageal Junction Cancer
NCT06558786
The Efficacy of Conventional Screening Versus mHealth Screening in Early Detection of Oral Potentially Malignant Disorders and Oral Cancer Amongst the Rural Population of Varanasi: A Prospective and Blinded Study
NCT06535867
Tislelizumab in People With Colorectal Cancer
NCT06529523
N10: A Study of Reduced Chemotherapy and Monoclonal Antibody (mAb)-Based Therapy in Children With Neuroblastoma
NCT06528496
A Study of Radiation Therapy After Surgery in People With Oral Tongue Squamous Cell Carcinoma
NCT06485778
A Study of Sacituzumab Govitecan in People With Mesothelioma
NCT06477419
A Study of Tinengotinib (TT-00420) in Combination With Standard Treatments in People With Prostate Cancer
NCT06457919
A Study of Emapalumab for Pediatric Aplastic Anemia
NCT06430788
A Registry for People With Lung Cancer
NCT06424327
A Study of Changes in Thinking Related to Aging and Cancer in Breast Cancer Survivors (TRAC)
NCT06334354
Ulixertinib in People With Histiocytic Neoplasms
NCT06411821
A Study of Avutometinib, Defactinib, and Letrozole in People With Low-Grade Serous Ovarian Cancer
NCT06394804
A Study of ADCLEC.syn1 in People With Acute Myeloid Leukemia
NCT05748197
A Study of BV-AVD in People With Bulky Hodgkin Lymphoma
NCT06377566
A Study Collecting Health Information to Understand and Prevent Gastric Cancer
NCT06370143
A Study of 2141-V11 in Combination With Standard Treatments in People With Prostate Cancer
NCT06347705
An Acupuncture Study for People At High Risk for Sepsis
NCT06344819
A Study of Opportunistic Salpingectomy to Prevent Ovarian Cancer
NCT06312124
A Study of an Anxiety Intervention for Latino/Latina/Hispanic Older Adults With Cancer and Their Caregivers
NCT06305741
Hyperpolarized C Pyruvate Magnetic Resonance Imaging, and Blood-Based Biomarkers for Early Detection of Pancreatic Adenocarcinoma in Patients With Intraductal Papillary Mucinous Neoplasms
NCT06305728
A Study of Pasireotide in People With Prolactinoma
NCT06295952
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 461 |
| Phase 2 | 640 |
| Phase 3 | 67 |
| Phase 4 | 8 |
Therapeutic Areas
What is open in the Memorial Sloan Kettering Cancer Center pipeline
327 recruiting of 1,884 indexed (17% open); 1,104 completed (59%).
Phase mix: 75 late (III/IV) vs 1,101 early (I/II) (early-phase heavy).
Top condition: Breast Cancer (98 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page aggregates every registered trial from this sponsor, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.